


Healthcare News Roundup: Neuro
HSMN NewsFeed - 7 Jun 2018
Centinel Spine Announces 510(k) Clearance of FLX(TM) Platform of 3D Printed All-Titanium Interbodies
Centinel Spine Announces 510(k) Clearance of FLX(TM) Platform of 3D Printed All-Titanium Interbodies
HSMN NewsFeed - 29 May 2018
Zeto Announces First Dry Electrode, Wireless EEG Headset Approved by FDA for Clinical Use
Zeto Announces First Dry Electrode, Wireless EEG Headset Approved by FDA for Clinical Use
HSMN NewsFeed - 28 May 2018
Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
HSMN NewsFeed - 21 May 2018
CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
HSMN NewsFeed - 15 May 2018
BrainQ Technologies Raises $8.8 Million to Treat Neurodisorders With Artificial Intelligence
BrainQ Technologies Raises $8.8 Million to Treat Neurodisorders With Artificial Intelligence
HSMN NewsFeed - 3 May 2018
Paradigm Spine Announces NASS Coverage Policy Recommendation For coflex(R) Interlaminar Stabilization(R)
Paradigm Spine Announces NASS Coverage Policy Recommendation For coflex(R) Interlaminar Stabilization(R)
HSMN NewsFeed - 2 May 2018
Paradigm Spine Receives FDA Pre-Market Approval (PMA) For First Of Its Kind Disposable Instrument Kit
Paradigm Spine Receives FDA Pre-Market Approval (PMA) For First Of Its Kind Disposable Instrument Kit
HSMN NewsFeed - 26 Apr 2018
Neuraltus Pharmaceuticals Reports Results from Phase 2 NP001 Study in Amyotrophic Lateral Sclerosis (ALS)
Neuraltus Pharmaceuticals Reports Results from Phase 2 NP001 Study in Amyotrophic Lateral Sclerosis (ALS)
HSMN NewsFeed - 24 Apr 2018
Boston Scientific Announces Positive Late-Breaking Data From The INTREPID Study
Boston Scientific Announces Positive Late-Breaking Data From The INTREPID Study
HSMN NewsFeed - 20 Apr 2018
UCB to Expand Epilepsy Portfolio With Strategic Acquisition of Midazolam Nasal Spray From Proximagen
UCB to Expand Epilepsy Portfolio With Strategic Acquisition of Midazolam Nasal Spray From Proximagen
